Table 3.
n total | n pathology | R | 95% CI | |
---|---|---|---|---|
Global systolic function, left ventricle | 129 | 26 | 0.83 | 0.71–0.93 |
Apparent regional dysfunction, left ventricle | 129 | 22 | 0.60 | 0.39–0.78 |
Global systolic function, right ventricle | 115 | 10 | 0.44 | 0.10–0.72 |
Size of left atrium | 117 | 68 | 0.61 | 0.48–0.72 |
Aortic calcification and stenosis | 119 | 37 | 0.67 | 0.52–0.80 |
Aortic regurgitation | 117 | 27 | 0.68 | 0.52–0.82 |
Mitral regurgitation | 123 | 54 | 0.53 | 0.37–0.68 |
Tricuspid regurgitation | 107 | 49 | 0.61 | 0.45–0.74 |
Pericardial effusion | 131 | 4 | 0.86 | 0.57–1.00 |
Pleural effusion | 151 | 20 | 0.83 | 0.67–0.94 |
Abdominal aorta | 52 | 2 | 0.70 | 0.49–1.00 |
Inferior vena cavaa | 94 | 0.45 | 0.24–0.62 |
Data presented as correlation coefficient (r) with 95% confidence interval achieved by bootstrapping.
n total, the total number who underwent both PHHE and reference imaging; n pathology, total number with the described pathology.
aContinuous variable, analysed by Pearson's correlation, all others analysed by Spearman's rank correlation.